Email not displaying properly? View email in your browser
Vertical-Talk Pharma   >  Metal Organic Framework
>  Advance Therapies for Stroke
>  Primary Hyperoxaluria
  September 2019   e-Newsletter Advertise | Editorial Calendar  
2019 ISPE Annual Meeting & Expo
Latest e-book
News
Thermo Fisher Scientific Signs Agreement with...
Boehringer Ingelheim Partners with...
Press Releases
Lineage Cell Therapeutics Receives CE Mark...
Annexon Biosciences Announces FDA Fast...
Events
01 - 03 Oct 2019
SynBioBeta 2019
10 - 11 Oct 2019
SPER Pharma 2019
15 - 17 Oct 2019
LabAsia 2019
Articles
>  Metal Organic Framework-Mesoporous Silica Nanoparticle Composite...
Chandan Adhikari, Assistant Professor, Lovely Professional University, India
Drug delivery system composed of mesoporous silica nanoparticles suffers from many drawbacks. Out of many challenges, two major challenges in drug delivery through mesoporous silica nanoparticles, are premature leakage and fast release of the drug molecules. Because of these most of the time efficiency of the drug delivery system become very low. In this work, Mesoporous Silica Nanoparticles (MSN) have been modified modified using zeolitic imidazole framework through formation of a hybrid system. An anticancer drug Doxorubicin was encapsulated...
Techno Trends
> WVU Researchers Map Crystals to Enhance Advance Therapies...
> Breakthrough Drug Introduced to Treat Primary Hyperoxaluria Type 1
Projects
> Colorcon Plans to Build a New Starch Manufacturing Unit
> Lonza Expands its Manufacturing Capabilities at Tampa Site
> Fujifilm Irvine Plans New Manufacturing Facility in Europe
Qatar Cargo
  Subscribe  |  e-Book Archives  | Advisory Board  
Follow Us Facebook Twitter Google-plus linkedin
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555